2003
DOI: 10.1016/s0006-3223(03)00787-x
|View full text |Cite
|
Sign up to set email alerts
|

Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
53
1
1

Year Published

2005
2005
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 99 publications
(56 citation statements)
references
References 40 publications
1
53
1
1
Order By: Relevance
“…In light of these findings, it is not surprising that differences in the effects of drugs of abuse in adolescent rodents, as compared to adult rodents, have been reported. For example, younger animals have been shown to develop less sensitization than adult animals following repeated exposure to stimulants such as cocaine [14], [29], amphetamine [28], and methylphenidate [9,10]. Similar results have been observed for alcohol [12], [39].…”
Section: Introductionmentioning
confidence: 61%
See 1 more Smart Citation
“…In light of these findings, it is not surprising that differences in the effects of drugs of abuse in adolescent rodents, as compared to adult rodents, have been reported. For example, younger animals have been shown to develop less sensitization than adult animals following repeated exposure to stimulants such as cocaine [14], [29], amphetamine [28], and methylphenidate [9,10]. Similar results have been observed for alcohol [12], [39].…”
Section: Introductionmentioning
confidence: 61%
“…Similar to ethanol, toluene interacts with GABA A receptors [1,2], suggesting that this mechanism may also contribute to the age differences observed in the present study. In addition, younger animals have been shown to develop less locomotor sensitization than adult animals following repeated exposure to other drugs of abuse such as alcohol [12], [39], cocaine [14], [29], amphetamine [28], and methylphenidate [9,10]. Together, these results suggest that initial sensitivity to the acute locomotor effects of toluene (and perhaps those of other inhalants) follows a developmental time-course in which sensitivity increases as rats leave adolescence and enter adulthood.…”
Section: Discussionmentioning
confidence: 94%
“…In a previous study in gerbils, adolescent treatment with methylphenidate normalized dopaminergic fiber density in animals with methamphetamine-lesioned brains, but it did not affect control animals (Grund et al, 2007). On the other hand, other studies have also reported long-lasting changes in healthy animals, eg, reduced striatal dopamine transporter densities (Moll et al, 2001) and altered firing rates of midbrain dopaminergic neurons (Brandon et al, 2003). In line with this, behaviorally, pre-adolescent treatment with methylphenidate increased aversion to cocaine and reduced response to its rewarding properties in adult rats (Andersen et al, 2002), while long-term oral treatment during adolescence hardly affected measures of anxietylike behavior in otherwise healthy rats (Britton and Bethancourt, 2009).…”
Section: Limited Effects Of Methylphenidate Exposure On Healthy Brainsmentioning
confidence: 85%
“…Animal models may therefore afford a well-controlled experimental setup to disentangle the effects of neuropathology and chronic psychostimulant treatment on the developing brain. Studies in rats have shown that early exposure to methylphenidate can affect midbrain dopaminergic neurons (Brandon et al, 2003), cause profound reductions in striatal dopamine transporter levels (Moll et al, 2001), but could also prevent methamphetamine-triggered suppression of dopaminergic innervation of the prefrontal cortex and amygdala (Grund et al, 2007). However, it remains unclear to what extent long-term exposure of the normally developing adolescent brain to methylphenidate-in the absence of ADHDaffects gross tissue morphology and function as observed in patient studies.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies reporting chronic effects in rats resulting from administration of MPH employed various routes, durations, and age intervals of administration (Greeley and Kizer, 1980;Bolanos et al, 2003;Carlezon et al, 2003;Brandon et al, 2003). Greeley and Kizer (1980) investigated the effects on growth and endocrine function in Sprague-Dawley rats of administering MPH via twice daily subcutaneous injections to male and females for 21 days beginning on 5-7 days of age at daily doses of 1, 3, 10, 35, or 100 mg/ kg, or for 18 days beginning on 18-21 days of age at daily doses of 35 or 100 mg/kg, twice daily, and to females for 30 days beginning on 21-23 days of age at daily doses of 35 or 100 mg/kg.…”
Section: Introductionmentioning
confidence: 99%